NewsRamp provides syndicated and curated news distribution and marketing services for major newswires.
May 8, 2026 — Strawberry Fields REIT reports Q1 2026 results with FFO rising to $20.9M, rental income up, and plans $300M credit facility. Learn about STRW's growth and healthcare property portfolio.
May 8, 2026 — Mayo Clinic AI detects pancreatic cancer signs 3 years early. Learn how this breakthrough could save lives through early diagnosis and treatment.
May 8, 2026 — AI-powered wearables are transforming health care by providing clinicians with meaningful insights. Apple Inc. leads the way in reliable wearables. TrillionDollarClub reports on these advances.
May 8, 2026 — DOJ task force targets tech-driven healthcare fraud in California, Arizona, and Nevada. Learn how this impacts digital health firms and patients. Read more on BioMedWire.
May 7, 2026 — MedCognetics and AWS partner with Health Within Reach Foundation to deploy AI-enabled mobile mammography units in India, bringing breast cancer screening to underserved populations.
May 7, 2026 — Lantern Pharma (LTRN) unveils next-gen withZeta.ai platform with ZetaSwarm and ZetaOmics for AI-driven cancer research and drug discovery. Learn about the new enterprise-grade capabilities.
May 7, 2026 — Oragenics (OGEN) and Sigyn Therapeutics sign letter of intent for exclusive license of CardioDialysis blood purification technology for traumatic brain injury and neurodegenerative diseases, complementing ONP-002 neurosteroid.
May 7, 2026 — HeartBeam (BEAT) partners with Atelier Health to expand cable-free 3D ECG technology into Southern California, completing initial U.S. markets. Learn about remote cardiac monitoring and preventive cardiology.
May 7, 2026 — Hantavirus outbreak on MV Hondius cruise ship kills three. Learn about symptoms, risks, and the role of Co-Diagnostics Inc. in detecting this deadly infection. Stay informed and safe.
May 7, 2026 — NanoViricides (NNVC) to present at D. Boral Capital Global Conference on May 7, 2026. CEO Anil Diwan to hold one-on-one meetings. Lead drug NV-387 targets RSV, COVID, influenza, and Monkeypox.
May 7, 2026 — Annovis Bio (NYSE: ANVS) CEO to present at Fierce Biotech Week about buntanetap, a multi-protein inhibitor for Alzheimer's and Parkinson's. Learn about the Phase 3 trial and innovative approach.
May 7, 2026 — April 2026 Wellness Index Report names top U.S. providers in the Superhuman Protocol Challenge, highlighting a shift from seasonal weight-loss to cellular-level health optimization with PEMF, EWOT, and red light therapy.
May 6, 2026 — Cardio Diagnostics Holdings uses AI and multi-omic biomarkers to detect cardiovascular disease from a blood sample, enabling personalized treatment and earlier intervention.
May 6, 2026 — Tonix Pharmaceuticals secures coverage for TONMYA, first new fibromyalgia drug in 15 years, covering 35M lives. Non-opioid treatment expands access. TNXP stock news.
May 6, 2026 — Oncotelic Therapeutics grants worldwide rights to its nose-to-brain delivery system for biodefense and Alzheimer's in exchange for $12.5M from Lunai Bioworks. Learn about the N2B platform.
May 6, 2026 — Johns Hopkins researchers find new approach to group 3 medulloblastoma by blocking energy metabolism. Mouse study shows promise for pediatric brain cancer treatment.
May 6, 2026 — BioAdaptives (BDPT) launches MyndRenew, a nighttime supplement for sleep and brain recovery. Learn about its 13 ingredients and the MyndSystem platform.
May 6, 2026 — VolitionRx submits clinical manuscript for Nu.Q Vet Feline assay, achieving 97% specificity in detecting lymphoma in cats. A $5 million milestone awaits publication. Learn more about this liquid biopsy test for feline cancer.
May 6, 2026 — Aclarion grants inducement stock option to new Commercial Director Daniel Keefe amid triple-digit growth in Nociscan utilization. Learn how Nociscan uses AI and biomarkers to identify chronic low back pain sources.
May 5, 2026 — Learn how a new study reveals cancer's strategy to reprogram immune cells into tumor allies, offering hope for improving immunotherapy response rates in patients.